8-K: Onconetix Secures Debt, Extends Veru Notes, Director Exits

Onconetix, Inc. issued a new promissory note for $117,647.06, amended and extended its $5.1 million debt to Veru Inc., and announced a director's resignation.

Summary

• Issued a promissory note to Keystone Capital Partners, LLC on August 6, 2025, for an aggregate principal of $117,647.06, with an original issue discount of $17,647.06, resulting in a purchase price of $100,000.
• The Keystone Note is due upon the earlier of sufficient proceeds from the company's Equity Line of Credit (ELOC) with Keystone or March 6, 2026, and is subordinate to existing debt obligations to Veru Inc.
• Any unpaid amounts on the Keystone Note will incur a late charge of 15% per annum.
• Amended and restated the September Veru Note on August 7, 2025, increasing the principal amount owed to Veru Inc. by $100,000 to an aggregate of $5.1 million.
• The maturity date for the Veru Notes was amended to August 14, 2025, following multiple previous extensions.
• The A&R September Veru Note now accrues interest at 10% per annum on any unpaid principal balance upon an Event of Default or payment default.
• Ajit Singh resigned as a member of the Board of Directors effective August 10, 2025, with no reported disagreements requiring disclosure.

Sentiment

Score: 3

Explanation: The company is facing severe liquidity issues, evidenced by repeated defaults on significant debt obligations and the need for multiple forbearance agreements. The new financing comes at a high cost, and the increase in principal owed to Veru Inc. further burdens the company. The director resignation, while stated as not due to disagreement, adds to a picture of instability.

Positives

• Secured additional financing of $100,000 (net of original issue discount) from Keystone Capital Partners, LLC, providing some capital infusion.
• Successfully negotiated multiple extensions and forbearance agreements on significant debt obligations to Veru Inc., temporarily alleviating immediate repayment pressure.

Negatives

• Required multiple forbearance agreements and waivers due to repeated failures to repay debt to Veru Inc. on original due dates, indicating ongoing liquidity challenges.
• Increased the principal amount owed to Veru Inc. by $100,000 on the September Veru Note, adding to the overall debt burden.
• The new Keystone Note includes a substantial original issue discount of $17,647.06 on a $117,647.06 principal, reflecting a high cost of capital.
• The Keystone Note carries a high late charge of 15% per annum on unpaid amounts.
• The Veru Notes now accrue 10% interest per annum upon default, increasing potential financial costs if obligations are not met.
• Repayment of the Keystone Note is contingent on proceeds from the Equity Line of Credit (ELOC), which may not be sufficient or timely.

Risks

• Liquidity Risk: Persistent inability to meet debt obligations to Veru Inc. on time, requiring repeated extensions, highlights severe ongoing liquidity challenges.
• Default Risk: Operating under multiple forbearance agreements and extensions, with new interest accrual terms upon default, increases the risk of further financial distress and potential acceleration of debt.
• High Cost of Capital: The significant original issue discount on the Keystone Note and the high late charge, coupled with 10% interest on defaulted Veru debt, indicate a very high cost of borrowing due to perceived financial risk.
• Reliance on ELOC: Repayment of the Keystone Note and other prior notes to Keystone is heavily reliant on sufficient proceeds from the Equity Line of Credit (ELOC), which introduces uncertainty regarding funding availability.
• Dilution Risk: Future utilization of the ELOC or other securities offerings for capital raises, as mentioned for mandatory prepayment, could lead to significant shareholder dilution.
• Operational Continuity Risk: Continued financial instability and the burden of high-cost debt could impede the company's ability to fund operations, research, and strategic growth initiatives.

Future Outlook

The company's ability to meet its debt obligations, particularly the Veru Notes due August 14, 2025, and the Keystone Note due March 6, 2026, is contingent on receiving sufficient proceeds from its Equity Line of Credit (ELOC) or other future capital raises. The ongoing need for debt extensions and high-cost financing suggests continued financial pressure.

Management Comments

• The Company believes that there are no matters requiring disclosure under Item 5.02(a)(iii) of Current Report on Form 8-K regarding Ajit Singh's resignation.

Industry Context

NA

Management Changes

Stakeholder Impact

• Shareholders: Face significant potential for dilution from future capital raises (ELOC, other offerings) required to cover ongoing debt obligations. The company's persistent financial distress and high cost of capital could negatively impact share price.
• Creditors (Veru Inc. & Keystone Capital Partners, LLC): Veru Inc. has demonstrated flexibility by granting multiple forbearance and extensions, but remains exposed to ongoing default risk. Keystone Capital Partners, LLC is providing high-cost debt, reflecting the company's elevated risk profile.
• Employees/Operations: Persistent financial instability and the burden of servicing high-cost debt could impact the company's ability to fund operations, retain talent, and pursue strategic initiatives, potentially leading to operational disruptions.

Next Steps

• Repay the Veru Notes by the amended maturity date of August 14, 2025.
• Repay the Keystone Note by March 6, 2026, or earlier upon receipt of sufficient ELOC proceeds or other capital raises.
• Actively utilize the Equity Line of Credit (ELOC) to generate proceeds for debt repayment.
• Pursue other securities offerings to raise additional capital as a means for mandatory prepayment of the Keystone Note and other obligations.

Key Dates

Recommendation

The company exhibits severe and persistent liquidity issues, evidenced by repeated defaults on significant debt obligations and the need for multiple forbearance agreements. The new financing secured from Keystone Capital Partners, LLC comes with a substantial original issue discount, indicating a very high cost of capital and reflecting the company's distressed financial state. Furthermore, the principal amount owed to Veru Inc. was increased, and new interest accrual terms upon default add to the financial burden. The reliance on an Equity Line of Credit and other future capital raises for debt repayment suggests ongoing dilution risk for shareholders. The resignation of a director, even without stated disagreement, contributes to a perception of instability. These factors collectively point to significant financial distress and a high probability of further negative developments, making the stock a strong sell.

Keywords

Onconetix, ONCO, SEC Filing, 8-K, Promissory Note, Debt Financing, Keystone Capital Partners, Veru Inc., Forbearance Agreement, Debt Extension, Original Issue Discount, Corporate Governance, Director Resignation, Liquidity, Financial Risk, Equity Line of Credit